Zusammenfassung
Die Prävention und Therapie von tiefen Beinvenenthrombosen und Lungenembolien bei Patienten mit akutem Schlaganfall (Ischämie und Blutung) stellen im klinischen Alltag eine besondere Herausforderung dar. Neben einer kurzen Übersicht zu Epidemiologie, Risikofaktoren und Ursachen von tiefen Beinvenenthrombosen und Lungenembolien bei Patienten mit akutem Schlaganfall fokussiert dieser Artikel auf die Sicherheit und Effektivität der prophylaktischen Anwendung von Kompressionsstrümpfen, Kompressionsgeräten und Antikoagulanzien. Es werden im Speziellen Behandlungsoptionen bei manifesten Thrombosen oder Lungenembolien vor dem Hintergrund des erhöhten Rezidivrisikos bei Patienten mit intrakranieller Blutung dargestellt.
Summary
Prevention and therapy of deep vein thrombosis and pulmonary embolisms in patients with acute stroke (ischemia and hemorrhage) represent a special challenge in the clinical routine. This article gives an overview on the epidemiology, risk factors and causes of deep vein thrombosis and pulmonary embolism in patients with acute stroke. The focus lies on the efficacy and safety of prophylactic treatment with compression stockings, compression devices and anticoagulants. Special therapeutic options in the event of symptomatic deep vein thrombosis and pulmonary embolisms in patients with intracerebral hemorrhage and increased risk of recurrent bleeding are presented.
Literatur
Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF) Ständige Kommission Leitlinien (2009) AWMF Regelwerk „Prophylaxe der venösen Thromboembolie (VTE)“. AWMF
Statistisches Bundesamt (2011) Gesundheit – Diagnosedaten der Patienten und Patientinnen in Krankenhäusern (einschl. Sterbe- und Stundenfälle). Wiesbaden
Feigin VL, Lawes CM, Bennett DA et al (2009) Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. Lancet Neurol 8(4):355–369
CLOTS Trials Collaboration (2013) Effectiveness of intermittent pneumatic compression in reduction of risk of deep vein thrombosis in patients who have had a stroke (CLOTS 3): a multicentre randomised controlled trial. Lancet 382:516–524
CLOTS Trials Collaboration, Dennis M, Sandercock PA et al (2009) Effectiveness of thigh-length graduated compression stockings to reduce the risk of deep vein thrombosis after stroke (CLOTS trial 1): a multicentre, randomised controlled trial. Lancet 373(9679):1958–1965
Kelly J, Rudd A, Lewis RR et al (2004) Venous thromboembolism after acute ischemic stroke: a prospective study using magnetic resonance direct thrombus imaging. Stroke 35:2320–2326
Gregory PC, Kuhlemeier KV (2003) Prevalence of venous thromboembolism in acute hemorrhagic and thrombembolic stroke. Am J Phys Med Rehabil 82:364–369
The German Stroke Registers Study Group (2004) Predictors of in-hospital mortality and attributable risks of death after ischemic stroke. Arch Intern Med 164:1761–1768
Pongmoragot I, Rabinstein AA, Nilanont Y et al (2013) Pulmonary embolism in ischemic stroke: clinical presentation, risk factors, and outcome. J Am Heart Assoc 2(6):e000372
Wells PS, Owen C, Doucette S et al (2006) Does this patient have deep vein thrombosis? JAMA 295:199–207
Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF) Ständige Kommission Leitlinien (2010) Diagnostik und Therapie der Venenthrombose und der Lungenembolie. AWMF
Dennis M, Mordi N, Graham C, Sandercock P (2011) The timing, extent, progression and regression of deep vein thrombosis in immobile stroke patients: observational data from the CLOTS multicenter randomized trials. J Thromb Haemost 9:2193–2200
Bounds JV, Wiebers DO, Whisnant JP, Okazaki H (1981) Mechanisms and timing of deaths from cerebral infarktion. Stroke 12(4):474–477
Bernhardt J, Dewey H, Thrift A et al (2008) A very early rehabilitation trial for stroke (AVERT): phase II safety and feasibility. Stroke 39(2):390–396
Sherman DG, Albers GW, Bladin C et al (2007) The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischaemic stroke (PREVAIL Study): an open-label randomised comparison. Lancet 369
PROTECT Trial Group (2006) Prophylaxis of thrombotic and embolic events in acute ischemic stroke with the low-molecular-weight heparin certoparin: results of the PROTECT Trial. Stroke 37(1):139–144
Geeganage CM, Sprigg N, Bath MW, Bath PMW (2013) Balance of symptomatic pulmonary embolism and symptomatic intracerebral hemorrhage with low-dose anticoagulation in recent ischemic stroke: a systematic review and meta-analysis of randomized controlled trials. J Stroke Cerebrovasc Dis 22(7):1018–1027
Veltkamp R (2012) Akuttherapie des ischämischen Schlaganfalls. In: Diener H-C, Putzki N, Berlit P, Hacke W, Hufnagel A, Hufschmidt A et al (Hrsg). Thieme, Stuttgart
Van Es N, Coppens M, Schulman S et al (2014) Direct oral anticoagulants compared with vitamin K antagonists for acute symptomatic venous thromboembolism: evidence from phase 3 trials. Blood [Epub ahead of print]
Heidbuchel H, Verhamme P, Alings M et al (2013) EHRA practical guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation: executive summary. Eur Heart J 34(27):2094–2106
Brott T, Broderick J, Kothari R et al (1997) Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke 28(1):1–5
Broderick JP, Brott TG, Duldner JE (1993) Volume of Intracerebral Hemorrhage: a powerful and easy-to-use predictor of 30-day mortality. Stroke 24:987–993
Orken DN, Kenangil G, Ozkurt H et al (2009) Prevention of deep venous thrombosis and pulmonary embolism in patients with acute intracerebral hemorrhage. Neurologist 15(6):329–331
Paciaroni M, Agnelli G, Venti M et al (2011) Efficacy and safety of anticoagulants in the prevention of venous thromboembolism in patients with acute cerebral hemorrhage: a meta-analysis of controlled studies. J Thromb Haemost 9(5):893–898
Steiner T, Beer R, Dichgans M et al (2012) Intrazerebrale Blutungen. In: Diener H-C, Putzki N, Berlit P, Hacke W, Hufnagel A, Hufschmidt A et al (Hrsg) Thieme, Stuttgart
CLOTS Trials Collaboration (2013) The effect of graduated compression stockings on long-term outcomes after stroke: the CLOTS trials 1 and 2. Stroke 44(4):1075–1079
Lacut K, Bressollette L, Le Gal G et al (2005) Prevention of venous thrombosis in patients with acute intracerebral hemorrhage. Neurology 65:865–869
Steiner T, Al-Shahi Salman R, Beer R et al (2014) ESO-guidelines for the management of spontaneous intracerebral haemorrhage. Int J Stroke (submitted)
Kelly J, Hunt BJ, Lewis RR, Rudd AA (2003) Anticoagulation or inferior vena cava filter placement for patients with primary intracerebral hemorrhage developing venous thromboembolism? Stroke 34:2999–3005
Hull RD, Raskob GE, Ginsberg JS et al (1994) A non-invasive strategy for the treatment of patients with suspected pulmonary embolism. Arch Intern Med 154:289–297
Decousus H, Leizorovicz A, Parent F et al (1998) A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. N Engl J Med 338:409–415
Ghanim AJ, Daskalakis C, Eschelman DJ, Kraft WK (2007) A five-year, retrospective, comparison review of survival in neurosurgical patients diagnosed with venous thromboembolism and treated with either inferior vena cava filters or anticoagulants. J Thromb Thrombolysis 24:247–254
Dennis M, Sandercock P, Reid J et al (2013) Effectiveness of intermittent pneumatic compression in reduction of risk of deep vein thrombosis in patients who have had a stroke (CLOTS 3): a multicentre randomised controlled trial. Lancet 382(9891):516–524
Einhaltung ethischer Richtlinien
Interessenkonflikt. J. Trabert gibt an, dass kein Interessenkonflikt besteht. T Steiner: Vortragshonorare von folgenden Firmen: Boehringer Ingelheim, Bayer, BMS Pfizer; Beraterhonorare: Boehringer Ingelheim, BMS Pfizer. Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Trabert, J., Steiner, T. Tiefe Beinvenenthrombosen und Lungenembolien beim Schlaganfall. Nervenarzt 85, 1315–1325 (2014). https://doi.org/10.1007/s00115-014-4031-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00115-014-4031-9